LSL Pharma Group Inc. Stock: price and insider trades · Canada

LSL Pharma Group Inc. belongs to the Health Care sector. Filings by its managers are published through SEDI. Between 18 October 2025 and 18 October 2026, 3 insiders published 10 filings.

No insider sold shares on the market over the period. Instead, the filings list 5 purchases totalling €33k, made by 2 insiders. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. The largest single trade was a purchase of €29k by Paradis, Mario, published on 19 June 2026, equal to 0.10% of the market capitalisation. Those buying include 2 senior executives.

For context, the typical company on the same exchange (median of 2,120 companies) published 12 filings over the same period, against 10 filings here. Our records for LSL Pharma Group Inc. go back to 2026, with 5 purchases and no sales on the open market in total.

The last purchase on record was published on 2 July 2026, which is 107 days ago. Between a trade and the moment it shows up on SEDI, the median delay is 2 days. This delay matters because a trade only becomes useful information once it is public.

For comparison within the same sector, see the insider buying recorded at MAIA Biotechnology, Inc. and Cooper Companies, Inc. Source: insider filings from SEDI. Past trades are no guide to future returns.